Expression of Transforming Growth Factor β1 and E-Cadherin Proteins in Pulmonary Adenocarcinoma: Its Significance in Tumor Progression
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose This study was conducted in order to investigate the significance of transforming growth factor β1 (TGFβ1) and E-cadherin proteins in tumor progression of lung adenocarcinoma and to evaluate their differential expression in association with morphologic characteristics. Materials and Methods A total of 65 pulmonary adenocarcinomas were reclassified according to the new classification system proposed by the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society. Tumor samples from 20 adenocarcinomas in situ (AIS, formerly bronchioloalveolar carcinoma [BAC]),9 minimally invasive adenocarcinomas (MIA, formerly BAC with ≤ 5 mm invasion), 17lepidic predominant adenocarcinomas (LPA, formerly mixed adenocarcinoma showing nonmucinous BAC features with >5 mm invasion), and 19 invasive adenocarcinomas with no BAC features were analyzed by immunohistochemistry for expression of TGFβ1 and E-cadherin proteins. Results TGFβ1 expression was detected in 46% (21/46) of noninvasive elements and 87%(39/45) of invasive elements (p=0.001). E-Cadherin expression was less frequent in invasive components than in noninvasive components (38% vs. 65%, p=0.009). Negative correlation was identified between TGFβ1 expression and E-cadherin expression in noninvasive elements (p=0.022). More importantly, significantly higher frequency of TGFβ1 expression was observed in noninvasive components of LPA (14/17, 82%),compared with those of either AIS (5/20, 25%) or MIA (2/9, 22%) (p=0.008). Conclusion Our data indicate involvement of both TGFβ1 and E-cadherin proteins in tumor progression of pulmonary adenocarcinoma. It is noteworthy that TGFβ1 up-regulation precedes alveolar destruction by invasion of tumor cells. TGFβ1 may thus have the potential to improve lung adenocarcinoma diagnostics and therapeutics.
Abstract
Purpose This study was conducted in order to investigate the significance of transforming growth factor β1 (TGFβ1) and E-cadherin proteins in tumor progression of lung adenocarcinoma and to evaluate their differential expression in association with morphologic characteristics. Materials and Methods A total of 65 pulmonary adenocarcinomas were reclassified according to the new classification system proposed by the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society. Tumor samples from 20 adenocarcinomas in situ (AIS, formerly bronchioloalveolar carcinoma [BAC]),9 minimally invasive adenocarcinomas (MIA, formerly BAC with ≤ 5 mm invasion), 17lepidic predominant adenocarcinomas (LPA, formerly mixed adenocarcinoma showing nonmucinous BAC features with >5 mm invasion), and 19 invasive adenocarcinomas with no BAC features were analyzed by immunohistochemistry for expression of TGFβ1 and E-cadherin proteins. Results TGFβ1 expression was detected in 46% (21/46) of noninvasive elements and 87%(39/45) of invasive elements (p=0.001). E-Cadherin expression was less frequent in invasive components than in noninvasive components (38% vs. 65%, p=0.009). Negative correlation was identified between TGFβ1 expression and E-cadherin expression in noninvasive elements (p=0.022). More importantly, significantly higher frequency of TGFβ1 expression was observed in noninvasive components of LPA (14/17, 82%),compared with those of either AIS (5/20, 25%) or MIA (2/9, 22%) (p=0.008). Conclusion Our data indicate involvement of both TGFβ1 and E-cadherin proteins in tumor progression of pulmonary adenocarcinoma. It is noteworthy that TGFβ1 up-regulation precedes alveolar destruction by invasion of tumor cells. TGFβ1 may thus have the potential to improve lung adenocarcinoma diagnostics and therapeutics.
참고문헌 (18)
- Travis WD, "World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart" (2004), IARC Press
- Yoshizawa A, "Impact of proposed IASLC", ATS, Mod Pathol, pp.2011, 24[DOI]
- Travis WD, "International Association for the Study of Lung Cancer", American Thoracic Society, J Thorac Oncol, pp.2011, 6[DOI]
- Soh J, "Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung", J Thorac Oncol, 3, pp.340~347 (2008)
- Aviel-Ronen S, "Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features", Proc Natl Acad Sci U S A, 105, pp.10155~10160 (2008)
- Aoyagi Y, "Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma", Cancer Res, 61, pp.7950~7954 (2001)
- Derynck R, "TGF-beta signaling in tumor suppression and cancer progression", Nat Genet, 29, pp.117~129 (2001)
- Roberts AB, "The two faces of transforming growth factor beta in carcinogenesis", Proc Natl Acad Sci U S A, 100, pp.8621~8623 (2003)
- Cao M, "MiR-23a regulates TGF-beta-induced epithelialmesenchymal transition by targeting E-cadherin in lung cancer cells", Int J Oncol, 41, pp.869~875 (2012)
- Herfs M, "Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting Ecadherin expression", Am J Pathol, 172, pp.1391~1402 (2008)
- Saito H, "The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma", Cancer, 86, pp.1455~1462 (1999)
- Awaya H, "Loss of expression of E-cadherin and betacatenin is associated with progression of pulmonary adenocarcinoma", Pathol Int, 55, pp.14~18 (2005)
- Hasegawa Y, "Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma", Cancer, 91, pp.964~971 (2001)
- Takanami I, "Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma", J Clin Pathol, 47, pp.1098~1100 (1994)
- Saji H, "Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues", Ann Thorac Cardiovasc Surg, 9, pp.295~300 (2003)
- Borczuk AC, "Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness", Am J Respir Crit Care Med, 172, pp.729~737 (2005)
- Kalogeraki A, "E-cadherin expression on fine-needle aspiration biopsies in primary lung adenocarcinomas is related to tumor differentiation and invasion", Anticancer Res, 23, pp.3367~3371 (2003)
- Zhang HJ, "Transforming growth factor-beta1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition", Mol Cell Biochem, 355, pp.309~314 (2011)